Patent · US Active

Hexokinase 2-specific inhibitors for use in acute central nervous system injury

US12319750B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD · CN

Inventors

Guangmei Yan · 流花街道, CN
Wei Yin · 流花街道, CN
Yuan Li · Shandong, CN
Bingzheng Lu · Longbeilingcun, CN
Longxiang Sheng · Longbeilingcun, CN

Key dates

Filing date	Jan 11, 2023
Grant date	Jun 3, 2025
Priority date	—
Expiry date	Jun 7, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are applications of a hexokinase 2-specific inhibitor in preparing a medicament for preventing and treating acute central nervous system injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.